Brand
Esperion
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Esperion and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-04-24FDA-DrugClass IIINEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
- 2023-09-13FDA-DrugClass IIINexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Failed dissolution specifications: below specification results at stability 12-month
Get notified about new Esperion recalls
Free weekly digest. We email when a new federal recall affects Esperion or anything else in your household.
Get the Sunday Brief